175221-03-1 Usage
Description
(1S,2S)-2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)carbonyl)cyclopropanecarboxylic acid is a complex organic compound with a unique molecular structure. It is characterized by its cyclopropanecarboxylic acid core, which is substituted with a carbonyl group connected to a cyclohexyloxy group. This cyclohexyloxy group has an isopropyl and a methyl substituent, making the molecule highly functional and versatile in its applications.
Uses
Used in Pharmaceutical Industry:
(1S,2S)-2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)carbonyl)cyclopropanecarboxylic acid is used as an intermediate in the synthesis of complex pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs with specific therapeutic properties.
Used in Synthetic Preparation:
(1S,2S)-2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)carbonyl)cyclopropanecarboxylic acid is used as a synthetic precursor for the preparation of biologically active compounds. For example, it was used in the synthetic preparation of Callipeltoside A, a compound that exhibits cytotoxicity against human bronchopulmonary non-small cell lung carcinoma. Its role in the synthesis of such compounds highlights its potential in contributing to the development of novel anticancer agents.
Check Digit Verification of cas no
The CAS Registry Mumber 175221-03-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,2 and 1 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 175221-03:
(8*1)+(7*7)+(6*5)+(5*2)+(4*2)+(3*1)+(2*0)+(1*3)=111
111 % 10 = 1
So 175221-03-1 is a valid CAS Registry Number.
175221-03-1Relevant articles and documents
RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND
-
Page/Page column 15; 17, (2020/01/24)
The present invention relates to a compound of formula (I) wherein R1, R2, and R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a radiolabeled ligand.
PYRIDINE AND PYRAZINE DERIVATIVES AS PREFERENTIAL CANNABINOID 2 AGONISTS
-
Page/Page column 49; 51; 52, (2020/01/24)
The invention relates to a compound of formula (I), wherein A1, A2 and R1-R5 are as defined in the description and in the claims. The compound of formula (I) can be used as cannabinoid 2 preferential agonist.
Callipeltoside A: assignment of absolute and relative configuration by total synthesis.
Trost, Barry M,Dirat, Olivier,Gunzner, Janet L
, p. 841 - 843 (2007/10/03)
-